Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

JCI - First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

Frontiers SARS-CoV-2 and the host-immune response

How Long Does Immunity Protect Us From COVID-19 Reinfection?

T cells will save us from COVID-19

Fact check: Vaccines offer safe, consistent protection from COVID-19

Vaccines, Free Full-Text

Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study - The Lancet Microbe

Virus-Specific T Cells From Cryopreserved Blood During an Emergent Virus Outbreak for a Potential Off-the-Shelf Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

PDF) Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Early human B cell signatures of the primary antibody response to mRNA vaccination

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19